Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
10:59am, Wednesday, 02'nd Aug 2023
Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
GSK sues Pfizer in US for patent infringement over RSV vaccine
09:34am, Wednesday, 02'nd Aug 2023
British biopharmaceutical giant GSK sued Pfizer in Delaware federal court on Wednesday, accusing Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo of violating GSK's patent rights in its riva
S&P 500 Gains and Losses Today: Pharma Stocks Fall After Pfizer, Merck Reports
06:05pm, Tuesday, 01'st Aug 2023
The S&P 500 finished 0.3% lower on Tuesday, Aug. 1, 2023, as weaker-than-expected earnings from pharmaceutical companies weighed on the broader index.
Pfizer Expects Signoff For New Covid Boosters As Soon As This Month. Here's What To Know—And Why They're Needed
04:48pm, Tuesday, 01'st Aug 2023
Pfizer and BioNTech expect to release a new Covid-19 booster shot designed to protect against the XXB.1.5 and XXB.1.6 variants.
Pfizer CEO: Damaged Plant Could Lead to Shortages
04:46pm, Tuesday, 01'st Aug 2023
A powerful tornado last month flattened a warehouse at the drug maker's Rocky Mount, North Carolina facility, and destroyed the plant's utilities.
Pfizer Inc. (PFE) Q2 2023 Earnings Call Transcript
03:03pm, Tuesday, 01'st Aug 2023
Pfizer Inc. (NYSE:PFE ) Q2 2023 Results Conference Call August 1, 2023 10:00 AM ET Company Participants Chris Stevo - SVP and Chief IR Officer Dr. Albert Bourla - Chairman and CEO Dave Denton - CFO Dr
Pfizer's (PFE) Q2 Earnings Beat, Sales Miss, Stock Declines
12:40pm, Tuesday, 01'st Aug 2023
Pfizer (PFE) beats estimates for second-quarter earnings but misses the same for sales. It trims the upper end of its revenue guidance range for 2023.
Pfizer Q2 Revenue Misses Expectations as COVID Product Demand Slumps
12:15pm, Tuesday, 01'st Aug 2023
Drugmaker Pfizer's Q2 earnings showed mixed results. EPS beat analyst expectations but revenue declined on falling demand for its COVID products.
Uber, Pfizer, JetBlue Beat Q2 Earnings, Miss Sales
11:55am, Tuesday, 01'st Aug 2023
After today's close, Advanced Micro Devices (AMD) will be the latest important tech stock reporting, and will join Starbucks (SBUX).
Sell This Overhyped AI Dividend Stock And Buy This SWAN Instead
11:14am, Tuesday, 01'st Aug 2023
This Tech dividend stock has become overvalued. I explain why taking gains is extremely important in any market. I offer 1 SWAN dividend replacement.
Pfizer (PFE) Surpasses Q2 Earnings Estimates
09:41am, Tuesday, 01'st Aug 2023
Pfizer (PFE) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $2.04 per share a year ago.
Pfizer slashes full-year sales forecast by $1B amidst decline in Covid-related product sales
09:14am, Tuesday, 01'st Aug 2023
Pfizer Inc (NYSE:PFE) reduced its full-year sales forecast by $1 billion following a decline in sales for Covid-related products. The pharmaceutical firm faced challenges in the second quarter as sale
Looking for a Bargain? 7 Blue-Chip Stocks to Buy That Are Down 5% in 2023
07:10am, Tuesday, 01'st Aug 2023
The allure of discounted blue-chip stocks shines brighter than ever amid the complex mosaic of the stock market. With the stock market witnessing a rise driven by a handful of names, the flip side rev
Pfizer beats on earnings, but revenue misses as Covid product sales plummet
06:54am, Tuesday, 01'st Aug 2023
Pfizer is in a transition period as it pivots away from its blockbuster Covid vaccine and drug Paxlovid while the world emerges from the pandemic.
Pfizer misses quarterly revenue estimates as COVID product sales decline
06:50am, Tuesday, 01'st Aug 2023
Pfizer Inc on Tuesday fell short of Wall Street estimates for quarterly revenue, hit by declining sales of its COVID-19 products. Total revenue for the second quarter at $12.73 billion missing analyst
